Status:
COMPLETED
Safety and Efficacy of Cryoballoon Pulmonary Vein Isolation : a Single Center Registry
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study was to assess the long-term success rates of pulmonary vein isolation using first and second generation cryoballoons in patients with paroxysmal and persistent atrial fibrillatio...
Detailed Description
The success of ablation is determined by the absence of recurrence of atrial fibrillation in the short term beyond 3 months, medium and long term on regular clinical follow-up and ECG holters. The pat...
Eligibility Criteria
Inclusion
- Patients with an indication for ablation of atrial fibrillation at the CHU of Grenoble since the use of this technique (November 2007) until November 2016:
- Paroxysmal atrial fibrillation resistant to antiarrhythmic treatment.
- Persistent atrial fibrillation.
- Patients ≥18 years
- Patients with discernment who signed consent for information on the ablation procedure before surgery.
Exclusion
- patient less than 18 years old
- patient who refused to sign informed consent for the procedure of ablation
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
1003 Patients enrolled
Trial Details
Trial ID
NCT03388658
Start Date
November 1 2007
End Date
May 1 2017
Last Update
January 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UniversityHospitalGrenoble
Grenoble, France, 38043